DICLOXACILLIN SODIUM
Active substance: dicloxacillin
CAPSULE · DICLOXACILLIN SODIUM 500 mg/1
United StatesActive
Marketing holder: Aurobindo Pharma Limited
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- DICLOXACILLIN SODIUM · 500 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-5bf1-73c7-bcc2-1f0b22ab5a7d,01a1208e-8b31-74d9-acb9-c1b56cb91d41,01a1208f-9269-7807-a25a-6c2b97e1045e,01a12093-6b2c-722b-9dfc-c375f02d3d5a,01a12094-5216-7cfe-b45a-d891a70c610f;count=10 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 59651-566
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 59651-566 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 59651-566 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 59651-566 · Verified 2026-10-09 · open in source